Ending Cervical Cancer in Canada is Possible
The Canadian Partnership Against Cancer is calling on partners in health care and communities across Canada to end cervical cancer in Canada by 2040. The Partnership is leading the development and implementation of a Canadian plan to achieve the World Health Organization (WHO)’s elimination goal in this country. The plan is to reach full HPV vaccination of boys and girls; to move to primary HPV testing plus offer self-sampling in cervical screening programs; and to ensure rigorous follow up when abnormalities are identified. This will advance women’s health and lead to the elimination of cervical cancer in Canada by 2040. Read more at partnershipagainstcancer.ca/cervical.
Abstract Submission Now Open!
Abstract submission for the 2023 Canadian Cancer Research Conference is now open. Submissions from the entire spectrum of cancer research topics are welcome. Abstract submission deadline: Friday, June 9, 2023. For more information, go to Read More »
Abstract submission for the 2023 Canadian Cancer Research Conference is now open. Submissions from the entire spectrum of cancer research topics are welcome. Abstract submission deadline: Friday, June 9, 2023. For more information, go to Read More »
The 3CTN EDI Framework and Toolkit is Launched
The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical tri... Read More »
The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical tri... Read More »